Self-sampling for cervical cancer screening tested in 7,100-person study
NCT ID NCT06843720
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to improve access to cervical cancer screening by using self-collection for HPV testing in safety net health systems. Researchers will interview patients, providers, and stakeholders to understand attitudes and develop training materials. The trial enrolls 7,100 participants and focuses on implementation rather than a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that self-collection for HPV testing is a practical way to increase cervical cancer screening in underserved communities.
- What could go wrong
- This is an observational/behavioral study, not a treatment trial. It focuses on implementation and attitudes, not on curing disease, so direct health benefits are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HR-HPV TESTING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States